-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Human chondroprotein-39 (YKL-40) is an inflammatory biomarker that has been reported to be involved in the developmental process
Recently, the authoritative journal in the field of cardiovascular diseases, JAHA, published a research article, which aims to explore the prognostic value
The researchers measured plasma YKL‐40 levels in 3377 participants in the Chinese Acute Ischemic Stroke Antihypertensive Treatment Trial (CATIS) and collected data on the outcome of
During the 3-month follow-up period, 828 participants (24.
Thus, the elevated level of YKL‐40 in the acute phase of ischemic stroke is associated with an increased risk of death and major disability 3 months after stroke, suggesting that YKL‐40 may be an important indicator
Original Source:
Tian Xu.
et al.
Plasma Human Cartilage Glycoprotein‐39 Is Associated With the Prognosis of Acute Ischemic Stroke.
JAHA.
2022.